Larvol Delta - Aridis-Receives-Agreement-from-the-European-Medicines-Agency-EMA-on-the-Clinical-Study-Design-and-a-Single-Conrmatory-Phase-3-Study-of-AR301

Salvecin (tosatoxumab) - Aridis

https://www.globenewswire.com/news-release/2023/07/17/2705972/0/en/Aridis-Receives-Agreement-from-the-European-Medicines-Agency-EMA-on-the-Clinical-Study-Design-and-a-Single-Confirmatory-Phase-3-Study-of-AR-301.html

Jul 17, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next